industry collaboration

Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

A nascent but growing consumer market for brain-computer interface technology is driving the development of sleek new tools for decoding brain activity.

The discovery of ancient clades of brittle stars at the bottom of the Pacific Ocean adds to concerns that commercial exploitation of the area could destroy numerous taxa before they’ve even been identified.

A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.

In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.

An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.

An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

In times of budget belt-tightening at the federal level, life-science researchers can keep their work supported through private sources.
 

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.

A report by a Canadian organization finds that industry-academia relationships compromise university investigators' liberty.  

Already a world leader in high-tech entrepreneurship, Israel is now flexing its biotech muscles.

Simply disclosing conflicts of interest is not enough.

The American Association of University Professors releases recommendations for maintaining academic freedom while collaborating with industry.